New Delhi: J.B. Chemicals & Pharmaceuticals Limited (JB Pharma) has recently announced that the Board of Directors of the company has approved the acquisition of portfolio of brands, for use and exploitation within India, from Dr Reddy's Laboratories Limited.JB Chemicals & Pharmaceuticals limited has entered into an agreement with Dr. Reddy's Laboratories Ltd. to acquire four of...
New Delhi: J.B. Chemicals & Pharmaceuticals Limited (JB Pharma) has recently announced that the Board of Directors of the company has approved the acquisition of portfolio of brands, for use and exploitation within India, from Dr Reddy's Laboratories Limited.
JB Chemicals & Pharmaceuticals limited has entered into an agreement with Dr. Reddy's Laboratories Ltd. to acquire four of its brands "Z&D", "Pedicloryl", "Pecef" and "Ezinapi" for the India market.
All four brands are focused on the paediatric segment in the country with a total covered market size of 1800 crores as per IQVIA data. The combined sales of these brands as per internal estimates was INR ~33 crores for FY 2021-22.
The acquisition has been done for a cash consideration of Rs 98.3 crores. The acquisition shall be funded primarily through long term debt.
"JB Pharma sees good growth potential from the acquired brands as they are synergistic with its paediatric segment and will help it significantly leverage its field force strength," JB Pharma said in a BSE filing.
Founded in 1976, J.B. Chemicals & Pharmaceuticals Laboratories (JBCPL) is a pharmaceutical company headquartered in India. In India, the Company has five brands among the top 300 brands in the country. The Company exports its finished formulations to over 30 countries including the USA. It has seven state-of-the-art manufacturing facilities in India including a dedicated manufacturing facility for medicated lozenges. The manufacturing facilities are certified by leading regulators across the world.
Dr. Reddy's Laboratories Ltd. is an integrated pharmaceutical company headquartered in Hyderabad, Telangana, India. Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Dr. Reddy's operates in markets across the globe. The company's major markets include - USA, India, Russia & CIS countries, and Europe.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd